Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Concomitant Systemic and Neuro-Meningeal Non-Hodgkin’s Lymphoma: The Role of Consolidation with Intensive Chemotherapy and Autologous Stem Cell Transplantation. a Retrospective Study of 65 Cases

Gandhi Damaj, MD PhD, Sarah Ivanoff, Diane Coso, MD, Loic Ysebaert, Sylvain Choquet, MD, Caroline Houillier, MD, Wajed Abarah, Zora Marjanovic, Reda Garidi, Momar Diouf, anne Claire Gac, Jehan Dupuis, MD, Franck Morschhauseur, Herve Ghesquieres, MDPhD, Carole Soussain, MD

Blood (2014) 124 (21): 3102.

https://doi.org/10.1182/blood.V124.21.3102.3102

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin’s Lymphoma and Hodgkin’s Lymphoma

Sylvain Garciaz, MD, Diane Coso, MD, Florence Broussais, MD, Jean-Marc Schiano, MD, Boris Calmels, PharmD, PhD, Colombe Saillard, MD, Lauris Boudin, MD, Sophie Amrane, Didier Blaise, MDPhD, Reda Bouabdallah, MD

Blood (2014) 124 (21): 2515.

https://doi.org/10.1182/blood.V124.21.2515.2515

Published: 2014

Journal Articles

Impact of Partial Response Versus Complete Response before RIC/RTC Allogeneic Stem Cell Transplantation on Survival in a Cohort of 115 Chemosensitive Advanced NHL

Sylvain Garciaz, MD, Anne Wanquet, MD, Luca Castagna, MD, Roberto Crocchiolo, MD, Sabine Fürst, MD, Samia Harbi, MD, Christian Chabannon, MD PhD, Florence Broussais, MD, Diane Coso, MD, Reda Bouabdallah, MD, Didier Blaise, MD

Blood (2014) 124 (21): 1246.

https://doi.org/10.1182/blood.V124.21.1246.1246

Published: 2014

Journal Articles

Feasibility and Efficacy of Tandem Autologous-Allogeneic Transplantation in a Cohort of 111 Patients Affected By High-Risk Hodgkin's and Non-Hodgkin's Lymphoma

Roberto Crocchiolo, MD PhD, Luca Castagna, MD, Sabine Fuerst, MD, Jean El Cheikh, MD, Barbara Sarina, MD, Stefania Bramanti, Angela Granata, MD, Lucio Morabito, MD, Laura Giordano, MD, Sylvain Garciaz, MD, Diane Coso, MD, Reda Bouabdallah, MD, Monica Balzarotti, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise, MD PhD

Blood (2014) 124 (21): 3863.

https://doi.org/10.1182/blood.V124.21.3863.3863

Published: 2014

Journal Articles

Role Of Allogeneic Transplant In Poor Risk CLL Patients: A Long-Term Monocentric Experience In 39 Patients

Therese Aurran-Schleinitz, MD, Anne Wanquet, Sabine Furst, MD, Benjamin Esterni, Ph.D., Reda Bouabdallah, MD, Diane Coso, MD, Christine Arnoulet, Pharm. D., Jean El Cheikh, MD, Catherine Faucher, MD, Luca Castagna, MD, Christian Chabannon, MD, PhD, Didier Blaise

Blood (2013) 122 (21): 5531.

https://doi.org/10.1182/blood.V122.21.5531.5531

Published: 2013

Journal Articles

Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up

Raynier Devillier, MD, Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Samia Harbi, Luca Castagna, Jean El Cheikh, MD, Angela Granata, Catherine Faucher, MD, Anne Marie Stoppa, Bilal Mohty, MD, Thomas Prebet, MD, PhD, Diane Coso, MD, Jerome Rey, MD, Reda Bouabdallah, MD, Norbert Vey, MD, Didier Blaise, MD

Blood (2013) 122 (21): 3364.

https://doi.org/10.1182/blood.V122.21.3364.3364

Published: 2013

Journal Articles

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

Roberto Crocchiolo, MD PhD, Sabine Fuerst, MD, Jean El-Cheikh, MD PhD, Angela Granata, Claire Oudin, Geoffroy Venton, Norbert Vey, Reda Bouabdallah, MD, Anne Marie Stoppa, Florence Broussais, MD, Aude Charbonnier, MD, PhD, Claude Lemarie, Diane Coso, MD, Thomas Prebet, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3029.

https://doi.org/10.1182/blood.V120.21.3029.3029

Published: 2012

Journal Articles

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Claire Oudin, Angela Granata, Geoffroy Venton, Claude Lemarie, Diane Coso, MD, Reda Bouabdallah, MD, Anne Marie Stoppa, Norbert Vey, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3031.

https://doi.org/10.1182/blood.V120.21.3031.3031

Published: 2012

Journal Articles

High Response RATE and NO Treatment Related Mortality After Brentuximab Vedotin Salvage Therapy Followed by Reduced Intensity Conditioning Regimen Allogeneic STEM CELL Transplantation (RIC-ALLO) in Patients with CD 30+ Lymphomas

Sabine Furst, MD, Reda Bouabdallah, MD, Diane Coso, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Angela Granata, Claire Oudin, Geoffroy Venton, Anne Marie Stoppa, Claude Lemarie, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4526.

https://doi.org/10.1182/blood.V120.21.4526.4526

Published: 2012

Journal Articles

Pilot Study of Lenalidomide-Rituximab Combination in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Vadim Ivanov, MD, PhD, Diane Coso, MD, Thérèse Aurran, MD, Jean Marc Schiano, MD, Anne-Marie Stoppa, MD, Jerome Rey, MD, Florence Broussais, MD, Didier Blaise, MD, Reda Bouabdallah, MD

Blood (2012) 120 (21): 3695.

https://doi.org/10.1182/blood.V120.21.3695.3695

Published: 2012

Journal Articles

Risk Factors of GANCICLOVIR–RELATED Neutropenia After Allogeneic STEM CELL Transplantation: A Retrospective Monocenter Study On 547 Patients

Geoffroy Venton, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Sabine Furst, MD, Angela Granata, Claire Oudin, Catherine Faucher, Diane Coso, MD, Reda Bouabdallah, MD, Pierre Berger, Norbert Vey, Patrick Ladaique, Christian Chabannon, MD, PhD, Michele Merlin, Didier Blaise, MD

Blood (2012) 120 (21): 4186.

https://doi.org/10.1182/blood.V120.21.4186.4186

Published: 2012

Journal Articles

Potential Synergic Effect of Lenalidomide-Rituximab Combination: Durable Complete Remissions in Refractory Diffuse Large B Cell Lymphoma

Vadim Ivanov, MD, PhD, Diane Coso, MD, Therese Aurran-Schleinitz, MD, Jean-Marc Schiano de Colella, MD, Anne-Marie Stoppa, MD, Jerome Rey, MD, Florence Broussais, MD, Didier Blaise, MD, Reda Bouabdallah, MD

Blood (2011) 118 (21): 4989.

https://doi.org/10.1182/blood.V118.21.4989.4989

Published: 2011

Journal Articles

Diffuse Large B-Cell Lymphoma in the Elderly: Outcome of Patients From a Single Center

Jean-Marc Schiano de Colella, MD, Diane Coso, MD, Benjamin Esterni, Ph.D., Anne-Marie Stoppa, Vadim Ivanov, MD, PhD, Thérèse Aurran, MD, Florence Broussais, MD, Jerome Rey, MD, Frederique Rousseau, MD, Maud Cecile, MD, Didier Blaise, MD, Reda Bouabdallah, MD

Blood (2011) 118 (21): 2693.

https://doi.org/10.1182/blood.V118.21.2693.2693

Published: 2011

Journal Articles

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Caroline Veuillen, PhD, Jerome Rey, MD, Rémy Castellano, PhD, Florence Orlanducci, Françoise Mallet, Sylvaine Just-Landi, Diane Coso, MD, Vadim Ivanov, MD, PhD, Xavier Carcopino, MD, Reda Bouabdallah, MD, Yves Collette, PhD, Cyril Fauriat, PhD, Daniel Olive, MD, PhD, Thérèse Aurran, MD

Blood (2011) 118 (21): 3876.

https://doi.org/10.1182/blood.V118.21.3876.3876

Published: 2011

Journal Articles

Positron Emission Tomography Status and Tandem High-Dose Therapy Favorably Influence Outcome of Patients with Relapsed and/or Refractory Hodgkin Lymphoma

Raynier Devillier, MD, Diane Coso, MD, Luca Castagna, MD, Isabelle Brenot-Rossi, MD, Antonella Anastasia, MD, Arturo Chitit, MD, Jean Marc Schiano, MD, Armando Santoro, MD, Christian Chabannon, MD, PhD, Monica Balzarotti, MD, Didier Blaise, MD, Reda Bouabdallah, MD

Blood (2011) 118 (21): 335.

https://doi.org/10.1182/blood.V118.21.335.335

Published: 2011

Journal Articles

Fertility in Female Patients After Allogeneic Stem Cell Transplantation Following Reduced-Intensity Conditioning (RIC allo-SCT)

Emmanuelle Assouline, Roberto Crocchiolo, MD, Thomas Prebet, MD, PhD, Sabine Furst, MD, Jean El-Cheikh, MD PhD, Broussais Florence, Diane Coso, MD, Aude Charbonnier, Christian Chabannon, MD, PhD, Norbert Vey, MD, Gamerre Marc, Didier Blaise, MD, Blandine Courbiere

Blood (2011) 118 (21): 3057.

https://doi.org/10.1182/blood.V118.21.3057.3057

Published: 2011

Journal Articles

Impact of the New Anti-Myeloma Drugs on Outcome of Allogeneic Stem-Cell Transplantation with Reduced-Intensity Conditioning in Patients with High-Risk Multiple Myeloma

Jean El-Cheikh, MD PhD, Roberto Crocchiolo, MD, Jean Marie Boher, PhD, Sabine Furst, MD, Anne Marie Stoppa, Catherine Faucher, MD, Luca Castagna, MD, Angela Granata, Claire Oudin, jean Marc schiano De Colella, Diane Coso, MD, Reda Bouabdallah, MD, Didier Blaise, MD

Blood (2011) 118 (21): 4456.

https://doi.org/10.1182/blood.V118.21.4456.4456

Published: 2011

Journal Articles

Autologous Transplantation Followed by Reduced-Intensity Allogeneic Transplantation Is Feasible in Patients with High-Risk Non-Hodgkin's Lymphoma

Roberto Crocchiolo, MD, Luca Castagna, MD, Sabine Furst, MD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Claire Oudin, Reda Bouabdallah, MD, Diane Coso, MD, Broussais Florence, Vadim Ivanov, MD, PhD, Schiano Jean Marc, Thérèse Aurran, MD, Christian Chabannon, MD, PhD, Monica Balzarotti, Armando Santoro, Didier Blaise, MD

Blood (2011) 118 (21): 3105.

https://doi.org/10.1182/blood.V118.21.3105.3105

Published: 2011

Journal Articles

A Restrospective Review of Peripheral T-Cell Lymphoma in a Single Institution Between 2000 and 2010

Florence Broussais, MD, Diane Coso, MD, Vadim Ivanov, MD, PhD, Thérèse Aurran, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, MD

Blood (2011) 118 (21): 1623.

https://doi.org/10.1182/blood.V118.21.1623.1623

Published: 2011

Journal Articles

Pre-Transplant Rituximab Is Associated with Reduced Rate of Acute GvHD After RIC-Allosct In Lymphoma Patients: Results From A Retrospective Monocenter Analysis.

Roberto Crocchiolo, Jr, Jean El Cheikh, Luca Castagna, Alix Helvig, Sabine Furst, Catherine Faucher, Alberto Vazquez, Nawel Belmecheri, Angela Granata, Diane Coso, MD, Reda Bouadaballah, Didier Blaise, MD

Blood (2010) 116 (21): 1319.

https://doi.org/10.1182/blood.V116.21.1319.1319

Published: 2010

NARROW

Concomitant Systemic and Neuro-Meningeal Non-Hodgkin’s Lymphoma: The Role of Consolidation with Intensive Chemotherapy and Autologous Stem Cell Transplantation. a Retrospective Study of 65 Cases

Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin’s Lymphoma and Hodgkin’s Lymphoma

Impact of Partial Response Versus Complete Response before RIC/RTC Allogeneic Stem Cell Transplantation on Survival in a Cohort of 115 Chemosensitive Advanced NHL

Feasibility and Efficacy of Tandem Autologous-Allogeneic Transplantation in a Cohort of 111 Patients Affected By High-Risk Hodgkin's and Non-Hodgkin's Lymphoma

Role Of Allogeneic Transplant In Poor Risk CLL Patients: A Long-Term Monocentric Experience In 39 Patients

Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

High Response RATE and NO Treatment Related Mortality After Brentuximab Vedotin Salvage Therapy Followed by Reduced Intensity Conditioning Regimen Allogeneic STEM CELL Transplantation (RIC-ALLO) in Patients with CD 30+ Lymphomas

Pilot Study of Lenalidomide-Rituximab Combination in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Risk Factors of GANCICLOVIR–RELATED Neutropenia After Allogeneic STEM CELL Transplantation: A Retrospective Monocenter Study On 547 Patients

Potential Synergic Effect of Lenalidomide-Rituximab Combination: Durable Complete Remissions in Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B-Cell Lymphoma in the Elderly: Outcome of Patients From a Single Center

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Positron Emission Tomography Status and Tandem High-Dose Therapy Favorably Influence Outcome of Patients with Relapsed and/or Refractory Hodgkin Lymphoma

Fertility in Female Patients After Allogeneic Stem Cell Transplantation Following Reduced-Intensity Conditioning (RIC allo-SCT)

Impact of the New Anti-Myeloma Drugs on Outcome of Allogeneic Stem-Cell Transplantation with Reduced-Intensity Conditioning in Patients with High-Risk Multiple Myeloma

Autologous Transplantation Followed by Reduced-Intensity Allogeneic Transplantation Is Feasible in Patients with High-Risk Non-Hodgkin's Lymphoma

A Restrospective Review of Peripheral T-Cell Lymphoma in a Single Institution Between 2000 and 2010

Pre-Transplant Rituximab Is Associated with Reduced Rate of Acute GvHD After RIC-Allosct In Lymphoma Patients: Results From A Retrospective Monocenter Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only